Cargando…

Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients

OBJECTIVES: Patients with gastrointestinal (GI) risk factors who take non-steroidal anti-inflammatory drugs (NSAIDs) should also take gastroprotective agents (GPAs). No studies have evaluated adherence and reasons for non-adherence to GPA and NSAID therapies. METHODS: This was a prospective, multice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanas, Angel, Polo-Tomás, Mónica, Roncales, Pilar, Gonzalez, Miguel A, Zapardiel, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Stomach
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368233/ https://www.ncbi.nlm.nih.gov/pubmed/22334248 http://dx.doi.org/10.1038/ajg.2012.13

Ejemplares similares

Corrigendum: Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients
por: Lanas, Angel, et al.
Publicado: (2012)

Competing Influences in the Management of Gastrointestinal Bleeding
por: Sonnenberg, Amnon
Publicado: (2012)

Impairment of Salivary Mucin Production Resulting in Declined Salivary Viscosity During Naproxen Administration as a Potential Link to Upper Alimentary Tract Mucosal Injury
por: Garcia, Cesar J, et al.
Publicado: (2013)

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
por: Sundar, Raghav, et al.
Publicado: (2022)

CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype
por: Barros, Rita, et al.
Publicado: (2010)

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
por: Deng, Niantao, et al.
Publicado: (2012)

Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers
por: Laine, Loren, et al.
Publicado: (2012)

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
por: Basu, P Patrick, et al.
Publicado: (2011)

GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
por: Cryer, Byron, et al.
Publicado: (2013)

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding
por: Scholtz, Samantha, et al.
Publicado: (2014)

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)

Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
por: Asada, Kiyoshi, et al.
Publicado: (2015)

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer
por: Qian, Jin, et al.
Publicado: (2015)

Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
por: Lin, Suling J, et al.
Publicado: (2015)

Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
por: Fang, Yu-Jen, et al.
Publicado: (2015)

POU2F2-oriented network promotes human gastric cancer metastasis
por: Wang, Si-Meng, et al.
Publicado: (2016)

MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome
por: Wang, Kunning, et al.
Publicado: (2016)

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
por: Wang, Ting-ting, et al.
Publicado: (2017)

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
por: Ferreira, Rui M, et al.
Publicado: (2018)

Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD)
por: Taylor, Fiona, et al.
Publicado: (2018)

Mucosal microbiome dysbiosis in gastric carcinogenesis
por: Coker, Olabisi Oluwabukola, et al.
Publicado: (2018)

Human gastric cancer modelling using organoids
por: Seidlitz, Therese, et al.
Publicado: (2019)

Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study
por: Cai, Quancai, et al.
Publicado: (2019)

Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection
por: Boccellato, Francesco, et al.
Publicado: (2019)

Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies
por: Wang, Zhaoming, et al.
Publicado: (2017)

Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication
por: Sung, Joseph J Y, et al.
Publicado: (2020)

Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles
por: Erawijantari, Pande Putu, et al.
Publicado: (2020)

MiR130b from Schlafen4(+) MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer
por: Ding, Lin, et al.
Publicado: (2020)

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach
por: Bockerstett, Kevin A, et al.
Publicado: (2020)

DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia
por: Krishnan, Vaidehi, et al.
Publicado: (2020)

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
por: Wang, Ruiping, et al.
Publicado: (2020)

Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis
por: Wang, Pin, et al.
Publicado: (2019)

MicroRNA-92a-1–5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia
por: Li, Ting, et al.
Publicado: (2019)

Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing
por: Zhang, Min, et al.
Publicado: (2021)

Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population
por: So, Jimmy Bok Yan, et al.
Publicado: (2021)

Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands
por: Chiang, Tsung-Hsien, et al.
Publicado: (2021)

Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom
por: Ye, Yizhou, et al.
Publicado: (2021)

Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination
por: Sundar, Raghav, et al.
Publicado: (2021)

Iqgap3-Ras axis drives stem cell proliferation in the stomach corpus during homoeostasis and repair
por: Matsuo, Junichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rujdrq76cb7jlsud0fn0ppkr5g